329 related articles for article (PubMed ID: 30538505)
1. Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach.
Srivastava S; Kamthania M; Singh S; Saxena AK; Sharma N
Infect Drug Resist; 2018; 11():2377-2391. PubMed ID: 30538505
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.
Srivastava S; Verma S; Kamthania M; Kaur R; Badyal RK; Saxena AK; Shin HJ; Kolbe M; Pandey KC
JMIR Bioinform Biotech; 2020; 1(1):e19371. PubMed ID: 32776022
[TBL] [Abstract][Full Text] [Related]
3. Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
Srivastava S; Verma S; Kamthania M; Saxena AK; Pandey KC; Pande V; Kolbe M
PLoS One; 2023; 18(3):e0282580. PubMed ID: 36920996
[TBL] [Abstract][Full Text] [Related]
4. Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics.
Srivastava S; Kamthania M; Kumar Pandey R; Kumar Saxena A; Saxena V; Kumar Singh S; Kumar Sharma R; Sharma N
J Biomol Struct Dyn; 2019 Oct; 37(16):4345-4360. PubMed ID: 30457455
[TBL] [Abstract][Full Text] [Related]
5. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
[TBL] [Abstract][Full Text] [Related]
6. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach.
Mahmud S; Rafi MO; Paul GK; Promi MM; Shimu MSS; Biswas S; Emran TB; Dhama K; Alyami SA; Moni MA; Saleh MA
Sci Rep; 2021 Jul; 11(1):15431. PubMed ID: 34326355
[TBL] [Abstract][Full Text] [Related]
7. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
[TBL] [Abstract][Full Text] [Related]
8. Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2.
Rahmani A; Baee M; Saleki K; Moradi S; Nouri HR
J Biomol Struct Dyn; 2022 Aug; 40(13):6097-6113. PubMed ID: 33509045
[TBL] [Abstract][Full Text] [Related]
9. Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach.
Ashfaq UA; Saleem S; Masoud MS; Ahmad M; Nahid N; Bhatti R; Almatroudi A; Khurshid M
PLoS One; 2021; 16(2):e0245072. PubMed ID: 33534822
[TBL] [Abstract][Full Text] [Related]
10. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
11. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
12. Exploring whole proteome to contrive multi-epitope-based vaccine for NeoCoV: An immunoinformtics and
Aziz S; Waqas M; Halim SA; Ali A; Iqbal A; Iqbal M; Khan A; Al-Harrasi A
Front Immunol; 2022; 13():956776. PubMed ID: 35990651
[TBL] [Abstract][Full Text] [Related]
13. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
[TBL] [Abstract][Full Text] [Related]
14. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A
PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358
[TBL] [Abstract][Full Text] [Related]
15. In silico design of a broad-spectrum multiepitope vaccine against influenza virus.
Yuan L; Li X; Li M; Bi R; Li Y; Song J; Li W; Yan M; Luo H; Sun C; Shu Y
Int J Biol Macromol; 2024 Jan; 254(Pt 3):128071. PubMed ID: 37967595
[TBL] [Abstract][Full Text] [Related]
16. Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection.
Narula A; Pandey RK; Khatoon N; Mishra A; Prajapati VK
Infect Genet Evol; 2018 Jul; 61():4-15. PubMed ID: 29535024
[TBL] [Abstract][Full Text] [Related]
17. In silico design and immunoinformatics analysis of a universal multi-epitope vaccine against monkeypox virus.
Sanami S; Nazarian S; Ahmad S; Raeisi E; Tahir Ul Qamar M; Tahmasebian S; Pazoki-Toroudi H; Fazeli M; Ghatreh Samani M
PLoS One; 2023; 18(5):e0286224. PubMed ID: 37220125
[TBL] [Abstract][Full Text] [Related]
18. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
[TBL] [Abstract][Full Text] [Related]
19. Towards a novel peptide vaccine for Middle East respiratory syndrome coronavirus and its possible use against pandemic COVID-19.
Khan S; Shaker B; Ahmad S; Abbasi SW; Arshad M; Haleem A; Ismail S; Zaib A; Sajjad W
J Mol Liq; 2021 Feb; 324():114706. PubMed ID: 33173250
[TBL] [Abstract][Full Text] [Related]
20. Novel "GaEl Antigenic Patches" Identified by a "Reverse Epitomics" Approach to Design Multipatch Vaccines against NIPAH Infection, a Silent Threat to Global Human Health.
Srivastava S; Kolbe M
ACS Omega; 2023 Sep; 8(35):31698-31713. PubMed ID: 37692250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
